The NIL program — short for name, image and likeness — is an extension of Dexcom’s Warriors program, a global community of over 25,000 everyday people and celebrities — including Lance Bass, Patti ...

J&J to invest $2 billion in North Carolina manufacturing following latest tariffs announcement; Serena Williams is the face ...

Here’s why pharma brands should pay attention to GEO, a method to craft content that appears in ChatGPT and other AI models.

Read your plan documents to confirm whether the treatment or service is covered. Pay attention to any exclusions or limitations. Deutscher’s plan documents say hearing tests are not covered. But even ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

Whistleblower claims Meta deliberately exaggerated the success of its Shops ads to mitigate revenue losses caused by Apple’s privacy restrictions on iOS tracking.

The first cohort of seniors to have contended — not always enthusiastically — with a digital society has reached the age when cognitive impairment becomes more common.

Medical marketers can import Swoop’s advanced audience segments into the iSpot dashboard in order to access deeper insights and channel optimization.

Viking’s stock craters on disappointing weight loss drug data; HHS’ mRNA reasoning faces scientific pushback; ...

UnitedHealth Group’s multibillion-dollar pharmacy benefit manager, Optum Rx, is suing five Kentucky counties in an attempt to force them out of national opioid litigation against the company.

Bristol Myers Squibb appointed Nathan Pennell, MD, PhD, FASCO, as SVP, worldwide head of medical affairs for hematology and oncology, effective August 18. Nucleus RadioPharma hired former Food and ...

Novo issues global hiring freeze for non-critical jobs; RFK, Jr. feuds with American Academy of Pediatrics; Why direct-to-consumer sales are unlikely to significantly lower drug costs.